Tender detail
Open-house agreements 2026-2
Summary
The tender concerns framework agreements for medicines with various active substances for the period from 01/07/2026 to 30/06/2028. It is an open-house model: suitable and interested pharmaceutical companies can join the agreement on the same terms throughout the contract period. The bidder must submit the required declarations, proof of registration, proof of liability insurance, medicine registration and marketing data, and confirmation of its own and third-party delivery capacity.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.